Lotus Eye Hospital and Institute Limited
NSE: LOTUSEYE BSE: LOTUSEYE
Prev Close
108.21
Open Price
107.5
Volume
30,864
Today Low / High
106.81 / 111.99
52 WK Low / High
54.99 / 147
Range
105 - 116
Prev Close
108.6
Open Price
107.5
Volume
1,833
Today Low / High
107.4 / 111
52 WK Low / High
55.31 / 147.6
Range
104 - 115
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 110.64 (target range: 105 - 116), reflecting a change of 2.43 (2.24563%). On the BSE, it is listed at 109.9 (target range: 104 - 115), showing a change of 1.3 (1.19705%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Lotus Eye Hospital and Institute Limited Graph
Lotus Eye Hospital and Institute Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Lotus Eye Hospital and Institute Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 110.64, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 109.90 | 111.00 | 99.90 - 122.10 |
| 112.10 | 89.68 - 134.52 | ||
| 113.20 | 79.24 - 147.16 | ||
| Bearish Scenario | 109.90 | 108.80 | 97.92 - 119.68 |
| 107.70 | 86.16 - 129.24 | ||
| 106.60 | 74.62 - 138.58 |
Overview of Lotus Eye Hospital and Institute Limited
ISIN
INE947I01017
Industry
Medical - Care Facilities
Vol.Avg
35,293
Market Cap
2,281,977,999
Last Dividend
0
Official Website
IPO Date
2008-07-11
DCF Diff
99.53
DCF
9
Financial Ratios Every Investor Needs
Stock Dividend of LOTUSEYE
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2023-09-18 | September 18, 23 | 0.5 | 0.5 | 2023-09-18 | 2023-10-25 | |
| 2022-09-08 | September 08, 22 | 0.5 | 0.5 | 2022-09-10 | 2022-10-22 | |
| 2021-09-08 | September 08, 21 | 0.5 | 0.5 | 2021-09-10 | 2021-10-17 | |
| 2018-09-14 | September 14, 18 | 0.5 | 0.5 | 2018-09-17 | 2018-10-24 | 2018-05-29 |
| 2017-08-02 | August 02, 17 | 0.5 | 0.5 | 2017-08-03 | 2017-09-09 | 2017-05-27 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 49.56 Cr | 39.52 Cr | 10.04 Cr | 0.2026 | 0.06 Cr | 2.37 Cr | 0.43 Cr | 0.74 Cr | 0.34 | 4.74 Cr | 0.0149 |
| 2024-03-31 | 48.21 Cr | 34.64 Cr | 13.57 Cr | 0.2814 | 0.05 Cr | 2.18 Cr | 10.05 Cr | 2.91 Cr | 1.40 | 7.94 Cr | 0.0605 |
| 2023-03-31 | 47.04 Cr | 34.91 Cr | 12.14 Cr | 0.2580 | 0.05 Cr | 2.05 Cr | 4.76 Cr | 4.08 Cr | 1.96 | 8.84 Cr | 0.0867 |
| 2022-03-31 | 38.91 Cr | 29.24 Cr | 19.25 Cr | 0.4948 | 0.08 Cr | 2.15 Cr | 3.47 Cr | 2.98 Cr | 1.44 | 6.81 Cr | 0.0767 |
| 2021-03-31 | 32.36 Cr | 23.79 Cr | 8.57 Cr | 0.2648 | 0.05 Cr | 0.52 Cr | 1.32 Cr | 1.57 Cr | 0.75 | 4.46 Cr | 0.0485 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.01 Cr | 69.57 Cr | 9.57 Cr | 60.0003 Cr | 3.43 Cr | -0.72 Cr | 3.83 Cr | 53.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 7.4246 Cr |
| 2024-03-31 | 2.65 Cr | 66.63 Cr | 7.22 Cr | 59.4092 Cr | 1.11 Cr | -1.54 Cr | 3.21 Cr | 48.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 6.2268 Cr |
| 2023-03-31 | 3.60 Cr | 63.19 Cr | 5.61 Cr | 57.5794 Cr | 1.10 Cr | -2.50 Cr | 2.79 Cr | 44.07 Cr | 0.00 Cr | 0.00 Cr | 0.95 Cr | 5.1916 Cr |
| 2022-03-31 | 3.79 Cr | 61.60 Cr | 6.99 Cr | 54.6086 Cr | 1.24 Cr | -2.55 Cr | 2.31 Cr | 43.95 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 5.7566 Cr |
| 2021-03-31 | 5.18 Cr | 59.23 Cr | 6.53 Cr | 52.6967 Cr | 0.40 Cr | -4.78 Cr | 1.78 Cr | 40.37 Cr | 0.00 Cr | 0.16 Cr | 0.00 Cr | 5.8176 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.7022 Cr | -4.3502 Cr | -1.2416 Cr | -2.1250 Cr | 1.3873 Cr | 4.1508 Cr | -4.8272 Cr | 0.7393 Cr | -1.2309 Cr | -0.0107 Cr | -0.6180 Cr |
| 2024-03-31 | 5.6834 Cr | -4.6327 Cr | -3.4018 Cr | 0.0403 Cr | -2.3511 Cr | 6.9295 Cr | -5.6431 Cr | 2.9145 Cr | -2.2646 Cr | -1.0398 Cr | -0.4210 Cr |
| 2023-03-31 | 4.3871 Cr | -2.1944 Cr | -1.7051 Cr | 1.2901 Cr | 0.4876 Cr | 9.2806 Cr | -3.0970 Cr | 5.6539 Cr | -0.5677 Cr | -1.0398 Cr | -0.4853 Cr |
| 2022-03-31 | 4.4115 Cr | -3.9355 Cr | -1.5754 Cr | -0.2734 Cr | -1.0994 Cr | 8.7930 Cr | -4.6849 Cr | 4.1035 Cr | -0.4137 Cr | -1.0336 Cr | -0.5258 Cr |
| 2021-03-31 | 2.7305 Cr | 0.4855 Cr | -0.3191 Cr | 2.2548 Cr | 2.8969 Cr | 9.8924 Cr | -0.4757 Cr | 1.9111 Cr | -0.2628 Cr | 0.0000 Cr | 0.3333 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 13.55 Cr | 11.06 Cr | 2.49 Cr | 0.1838 | -0.33 Cr | -0.26 Cr | -0.13 | 0.66 Cr | -0.0192 |
| 2025-09-30 | 13.04 Cr | 6.90 Cr | 6.14 Cr | 0.4711 | -0.07 Cr | 0.12 Cr | 0.06 | 1.04 Cr | 0.0089 |
| 2025-06-30 | 13.52 Cr | 6.80 Cr | 6.72 Cr | 0.4970 | 0.66 Cr | 0.54 Cr | 0.26 | 1.67 Cr | 0.0403 |
| 2025-03-31 | 11.51 Cr | 8.47 Cr | 3.04 Cr | 0.2644 | 0.42 Cr | 0.25 Cr | 0.12 | 0.35 Cr | 0.0219 |
| 2024-12-31 | 12.25 Cr | 6.17 Cr | 6.08 Cr | 0.4962 | -0.52 Cr | -0.24 Cr | -0.11 | 1.01 Cr | -0.0195 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 1.48 Cr | 1.77 Cr | 3.25 Cr | 1.44 Cr | 3.70 Cr | 10.41 Cr | 55.00 Cr | 71.51 Cr | 10.90 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 4.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -60.00 Cr |
| 2025-03-31 | 4.15 Cr | 0.00 Cr | 4.15 Cr | 1.32 Cr | 3.83 Cr | 11.57 Cr | 53.94 Cr | 69.57 Cr | 9.57 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 4.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -60.11 Cr |
| 2024-09-30 | 0.31 Cr | 4.24 Cr | 4.54 Cr | 1.56 Cr | 3.89 Cr | 11.78 Cr | 52.77 Cr | 70.07 Cr | 9.97 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 0.25 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -0.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.10 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,750.00 | ₹1,114,331,091,750.00 | ₹163,093.00 |
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,084.00 | ₹1,054,832,568,100.00 | ₹863,039.00 |
| Fortis Healthcare Limited | FORTIS | ₹931.00 | ₹702,866,035,788.00 | ₹776,235.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,862.00 | ₹378,171,892,770.00 | ₹220,258.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹646.05 | ₹333,966,849,083.00 | ₹199,418.00 |
| Global Health Limited | MEDANTA | ₹1,160.80 | ₹312,011,861,496.00 | ₹187,239.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹726.25 | ₹290,600,901,544.00 | ₹144,224.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,207.00 | ₹122,581,906,120.00 | ₹18,617.00 |
| Jupiter Life Line Hospitals Limited | JLHL | ₹1,281.40 | ₹84,016,300,591.00 | ₹9,383.00 |
| HealthCare Global Enterprises Limited | HCG | ₹580.35 | ₹81,833,782,133.00 | ₹97,602.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹700.85 | ₹67,529,951,103.00 | ₹151,181.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹407.65 | ₹37,370,498,450.00 | ₹71,727.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹233.58 | ₹36,786,293,934.00 | ₹36,783.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Key Executives
Gender: Not Specified
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1957
Gender: female
Year Born: 1978
FAQs about Lotus Eye Hospital and Institute Limited
The CEO is Sangeetha Sundaramoorthy.
The current price is ₹109.73.
The range is ₹54.99-147.
The market capitalization is ₹228.20 crores.
The P/E ratio is 349.89.
The company operates in the Healthcare sector.
Overview of Lotus Eye Hospital and Institute Limited (ISIN: INE947I01017) is a leading Medical - Care Facilities in India. With a market capitalization of ₹228.20 crores and an average daily volume of 35,293 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.